Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Vertex Pharmaceuticals (VRTX) ended the recent trading session at $416.81, demonstrating a +2.01% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's ...
Hwbot officially validated a new DDR5 overclocking record after German overclocker "Sergmann" pushed a single module to 6,504.9 MHz. The feat hit 13,010 megatransfers per second ...
As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Anthropic’s latest small model, Claude Haiku 4.5, has arrived and it’s rewriting expectations for what a “lightweight” AI can ...
The Conestoga Small Cap Composite was unable to keep up with the benchmark's torrid pace, with a return of -1.4% net-of-fees ...
Trinasolar, a global leader in smart PV and energy storage solutions, showcased its latest innovations at Solar & Storage Live KSA 2025, held from 12 to 14 October at the Riyadh Front Exhibition & ...
At the exhibition, Trinasolar is showcasing a comprehensive portfolio of products that suit the Kingdom’s clean-energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results